Clinical Experience Shows That Catastrophic Late Effects Associated With Ablative Fractionation Can Be Avoided by Technological Innovation

Seminars in Radiation Oncology

Volumn 18, Issue 4, 2008, Pages 223-228

  Kavanagh, Brian ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATIVE FRACTIONATION; ARTICLE; CANCER RADIOTHERAPY; CLINICAL PRACTICE; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; LOW DRUG DOSE; LUNG CANCER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION MYELOPATHY; RADIATION RESPONSE; RISK FACTOR; SAFETY; SPINAL CORD; STEREOTACTIC BODY RADIATION THERAPY; THERAPEUTIC ERROR; TOXICITY;

DOSE FRACTIONATION; HUMANS; NEOPLASMS; RADIATION INJURIES; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 49849098243     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2008.04.002     Document Type: Article

References (28)

1. Macbeth F.R., Wheldon T.E., and Girling D.J. Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 8 (1996) 176-181
2. Dische S., and Saunders M.I. Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity. Radiother Oncol 16 (1989) 65-72
3. Schultheiss T.E. Spinal cord radiation "tolerance": Doctrine vs. data. Int J Radiat Oncol Biol Phys 30 (1994) 735-736
4. Kavanagh B.D., Lyckholm L., and Sugarman J. Ethics, professional values, and legal considerations in radiation oncology. In: Perez C.A., Brady L.W., and Halperin E.C. (Eds). Principles and Practice of Radiation Oncology. (ed 4) (2004), Lippincott Williams & Wilkins, Philadelphia, PA 2461-2470 chapter 91
5. Lovelock D.M., Hua C., and Wang P. Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. Med Phys 32 (2005) 2606-2614
6. Ryu S., Jin J.Y., and Jin R. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 109 (2007) 628-636
7. Chang E.L., Shiu A.S., and Mendel E. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7 (2007) 151-160
8. Bijl H.P., van Luijk P., and Coppes R.P. Dose-volume effects in the rat cervical spinal cord after proton irradiation. Int J Radiat Oncol Biol Phys 52 (2002) 205-211
9. Bijl H.P., van Luijk P., and Coppes R.P. Regional differences in radiosensitivity across the rat cervical spinal cord. Int J Radiat Oncol Biol Phys 61 (2005) 543-551
10. Wisnivesky J.P., Bonomi M., and Henschke C. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 128 (2005) 1461-1467
11. Darby S.C., McGale P., and Taylor C.W. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6 (2005) 557-565
12. Roach III M., Gandara D.R., and Yuo H.S. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J Clin Oncol 13 (1995) 2606-2612
13. Schneider R.A., Schultze J., and Jensen J.M. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity: Results in 257 consecutive patients. Strahlenther Onkol 183 (2007) 545-551
14. Carver J.R., Shapiro C.L., and Ng A. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects. J Clin Oncol 25 (2007) 3991-4008
15. McGarry R.C., Papiez L., and Williams M. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
16. Yamashita H., Nakagawa K., and Nakamura N. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2 (2007) 21
17. Timmerman R., McGarry R., and Yiannoutsos C. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
18. Miller K.L., Shafman T.D., and Anscher M.S. Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer?. Int J Radiat Oncol Biol Phys 61 (2005) 64-69
19. Kavanagh B.D., Ding M., and Schefter T.E. The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors. J Appl Clin Med Phys 7 (2006) 58-63
20. Kupelian P.A., Willoughby T.R., and Reddy C.A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 68 (2007) 1424-1430
21. Madsen B.L., Hsi R.A., and Pham H.T. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results. Int J Radiat Oncol Biol Phys 67 (2007) 1099-1105
22. Vargas C.E., Martinez A.A., and Boike T.P. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study. Int J Radiat Oncol Biol Phys 66 (2006) 416-423
23. Grills I.S., Martinez A.A., and Hollander M. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171 (2004) 1098-1104
24. Maxon H.R., Thomas S.R., and Hertzberg V.S. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309 (1983) 937-941
25. Li X.A., Wang J.Z., and Stewart R.D. Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose. Br J Radiol 81 (2008) 59-68
26. Coutard H. The conception of periodicity as a possible directing factor in the roentgentherapy of cancer. Twelfth Lewis Linn Mc Arthur Lecture of the Frank Billings Foundation. Delivered before the Institute of Medicine of Chicago and the Chicago Laryngological and Otological Society, October 1, 1935. Cited in Archambeau JO, Slater JM. Skin as a biologic dosimeter. Int J Radiat Oncol Biol Phys 60 (2004) 351-352
27. Edmundson M. Defender of the faith? (2007), Times Magazine, New York September 9
28. Lazaridis N. Sigmund Freud's oral cancer. Br J Oral Maxillofac Surg 41 (2003) 78-83